GOLDMAN SACHS GROUP INC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 52 filers reported holding SECOND SIGHT MED PRODS INC in Q3 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q3 2019$13,000
-7.1%
15,746
-8.6%
0.00%
Q2 2019$14,000
-33.3%
17,222
-33.6%
0.00%
Q1 2019$21,000
+10.5%
25,938
+20.8%
0.00%
Q4 2018$19,000
-68.9%
21,464
-33.7%
0.00%
Q3 2018$61,000
+22.0%
32,357
+7.4%
0.00%
Q2 2018$50,000
-13.8%
30,133
-0.8%
0.00%
Q1 2018$58,000
-12.1%
30,375
-12.1%
0.00%
Q4 2017$66,000
+112.9%
34,546
+31.9%
0.00%
Q3 2017$31,000
-65.6%
26,200
-63.2%
0.00%
Q2 2017$90,000
+462.5%
71,193
+442.5%
0.00%
Q1 2017$16,000
-96.3%
13,123
-89.3%
0.00%
Q2 2016$437,000
+18.4%
122,095
+59.7%
0.00%
Q1 2016$369,000
+25.1%
76,451
+52.4%
0.00%
Q4 2015$295,000
-52.1%
50,162
-51.7%
0.00%
Q3 2015$616,000
+28.6%
103,876
+194.7%
0.00%
Q2 2015$479,000
+1.1%
35,244
-4.8%
0.00%
Q1 2015$474,000
-9.2%
37,007
-27.3%
0.00%
Q4 2014$522,00050,8900.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,492,975$5,616,219,0004.42%
CARL DOMINO INC 112,719$142,0000.16%
VAN DEN BERG MANAGEMENT I, INC 243,679$307,0000.04%
ELEMENT CAPITAL MANAGEMENT LLC 112,735$142,0000.03%
Psagot Value Holdings Ltd. 195,999$247,0000.01%
ORACLE INVESTMENT MANAGEMENT INC 50,804$64,0000.01%
B. Riley Wealth Advisors, Inc. 28,927$37,0000.01%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 18,894$24,0000.01%
WEALTHSOURCE PARTNERS, LLC 10,000$13,0000.00%
LMR Partners LLP 50,168$63,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders